Remove 2000 Remove Cannabis Remove Clinical Trials Remove Treatment
article thumbnail

Knowde Group Inc.™ Enters Into a Strategic Partnership with LMC Manna Research to Drive Quality and Collaboration in the Conduct of Cannabis and Psychedelic Clinical Trials.

Cannabis Law Report

There is an urgent need for objective, scientifically sound and robust clinical trials to support medicinal cannabis and psychedelics (psilocybin, MDMA, LSD, Ketamine). Collectively, between the two organizations we offer a full-service package from protocol development to timely and successful clinical trial execution.”.

article thumbnail

Medical Marijuana is Being Used to Treat Dementia With Success

FloridaMarijuana.net

The Dementia Society of America attributes Dementia to rising healthcare costs as billions are spent each year for treatments and research. They estimate that the number of people aged 65 years and older is expected to increase from 35 million in 2000 to 71 million in 2030. million in 2000 to 19.5 million in 2030.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Which States Are Voting on Psychedelics?

Veriheal

Using psilocybin in small doses, or microdosing, has been shown to aid in the treatment of various mental health issues, including anxiety, depression, PTSD, and obsessive-compulsive disorder. Johns Hopkins University first received regulatory approval for psychedelic research in the year 2000. Connecticut Gov. Minnesota Rep.

article thumbnail

Relief the Natural Way: CBD Oil for Stress and Anxiety

Otherside Farms

The History Behind Cannabis as Medicine. It was recognized by the emperor at the time, Shen-Nung, as a treatment for over 100 different ailments. Around 200 BC, the Greeks were prescribing cannabis as a remedy for toothaches and earaches. Fast forward over 2000 years to 1992. A New Kind of Treatment.

Oil 70
article thumbnail

Why we haven’t cured cancer

Otherside Farms

Differential effects of repeated low dose treatment with the cannabinoid agonist WIN 55,212-2 in experimental models of bone cancer pain and neuropathic pain. Cannabis offers hope to arthritis sufferers (news – 2009). International Association for Cannabis as Medicine. International Association for Cannabis as Medicine.

article thumbnail

CBD is Everywhere – But Where Does the FDA Stand?

The Blunt Truth

The public hearing attracted over 100 speakers and 2000 participants. In each instance, the companies were selling products with flagrant disease-related claims that the FDA had not approved for the treatment or prevention of any ailments. In 2019, the FDA issued warning letters to four companies marketing and selling CBD products.

CBD 80
article thumbnail

Study: Oral CBD Use Has Anxiolytic and Anti-Psychotic Activity

The Joint Blog

This is according to a study published in the Journal of Clinical Medicine Research and epublished by the U.S. For the study researchers with the Nordic Cannabis Research Institute in Denmark reviewed 25 clinical trials assessing the safety and efficacy of CBD in various populations. National Institute of Health.